-
1
-
-
33646436171
-
Nonsteroidal anti-inflammatory drugs and the esophageal inflammation-metaplasia-adenocarcinoma sequence
-
Anderson LA, Johnston BT, Watson RG, et al. Nonsteroidal anti-inflammatory drugs and the esophageal inflammation-metaplasia- adenocarcinoma sequence. Cancer Res 2006;66:4975-82.
-
(2006)
Cancer Res
, vol.66
, pp. 4975-4982
-
-
Anderson, L.A.1
Johnston, B.T.2
Watson, R.G.3
-
3
-
-
0141465060
-
Reflux, Barrett's oesophagus and adenocarcinoma: Burning questions
-
Wild CP, Hardie LJ. Reflux, Barrett's oesophagus and adenocarcinoma: burning questions. Nat Rev Cancer 2003;3:676-84.
-
(2003)
Nat Rev Cancer
, vol.3
, pp. 676-684
-
-
Wild, C.P.1
Hardie, L.J.2
-
4
-
-
33744955457
-
Colorectal cancer in inflammatory bowel disease: Molecular and clinical considerations
-
Rubin DT, Parekh N. Colorectal cancer in inflammatory bowel disease: molecular and clinical considerations. Curr Treat Options Gastroenterol 2006;9:211-20.
-
(2006)
Curr Treat Options Gastroenterol
, vol.9
, pp. 211-220
-
-
Rubin, D.T.1
Parekh, N.2
-
5
-
-
0001414857
-
Distinct cytokine patterns in Barrett's oesophagus and associated adenocarcinoma: Evidence for a shift towards a Th-2 response
-
Onwuegbusi BA, Fitzgerald RC, Bajaj-Elliott M, Burnham WR, Farthing MJ. Distinct cytokine patterns in Barrett's oesophagus and associated adenocarcinoma: evidence for a shift towards a Th-2 response. Gastroenterology 2000;118:413.
-
(2000)
Gastroenterology
, vol.118
, pp. 413
-
-
Onwuegbusi, B.A.1
Fitzgerald, R.C.2
Bajaj-Elliott, M.3
Burnham, W.R.4
Farthing, M.J.5
-
6
-
-
18544367202
-
Tumour necrosis factor-alpha in Barrett's oesophagus: A potential novel mechanism of action
-
Tselepis C, Perry I, Dawson C, et al. Tumour necrosis factor-alpha in Barrett's oesophagus: a potential novel mechanism of action. Oncogene 2002;21:6071-81.
-
(2002)
Oncogene
, vol.21
, pp. 6071-6081
-
-
Tselepis, C.1
Perry, I.2
Dawson, C.3
-
7
-
-
0035811625
-
Hepatitis C virus infection
-
Lauer GM, Walker BD. Hepatitis C virus infection. N Engl J Med 2001;345:41-52.
-
(2001)
N Engl J Med
, vol.345
, pp. 41-52
-
-
Lauer, G.M.1
Walker, B.D.2
-
8
-
-
0032580479
-
HIV-protease inhibitors
-
Flexner C. HIV-protease inhibitors. N Engl J Med 1998;338:1281-92.
-
(1998)
N Engl J Med
, vol.338
, pp. 1281-1292
-
-
Flexner, C.1
-
9
-
-
0035913260
-
Management of tuberculosis in the United States
-
Small PM, Fujiwara PI. Management of tuberculosis in the United States. N Engl J Med 2001;345:189-200.
-
(2001)
N Engl J Med
, vol.345
, pp. 189-200
-
-
Small, P.M.1
Fujiwara, P.I.2
-
10
-
-
0033580405
-
Symptomatic gastroesophageal reflux as a risk factor for esophageal adenocarcinoma
-
DOI 10.1056/NEJM199903183401101
-
Lagergren J, Bergstrom R, Lindgren A, Nyren O. Symptomatic gastroesophageal reflux as a risk factor for esophageal adenocarcinoma. N Engl J Med 1999;340:825-31. (Pubitemid 29142625)
-
(1999)
New England Journal of Medicine
, vol.340
, Issue.11
, pp. 825-831
-
-
Lagergren, J.1
Bergstrom, R.2
Lindgren, A.3
Nyren, O.4
-
11
-
-
26944473246
-
Annual report to the nation on the status of cancer, 1975-2002, featuring population-based trends in cancer treatment
-
Edwards BK, Brown ML, Wingo PA, et al. Annual report to the nation on the status of cancer, 1975-2002, featuring population-based trends in cancer treatment. J Natl Cancer Inst 2005;97:1407-27.
-
(2005)
J Natl Cancer Inst
, vol.97
, pp. 1407-1427
-
-
Edwards, B.K.1
Brown, M.L.2
Wingo, P.A.3
-
12
-
-
0037382288
-
Ursodeoxycholic acid as a chemopreventive agent in patients with ulcerative colitis and primary sclerosing cholangitis
-
Pardi DS, Loftus EV, Jr., Kremers WK, Keach J, Lindor KD. Ursodeoxycholic acid as a chemopreventive agent in patients with ulcerative colitis and primary sclerosing cholangitis. Gastroenterology 2003;124:889-93.
-
(2003)
Gastroenterology
, vol.124
, pp. 889-893
-
-
Pardi, D.S.1
Loftus Jr., E.V.2
Kremers, W.K.3
Keach, J.4
Lindor, K.D.5
-
13
-
-
0031047361
-
Mayo Primary Sclerosing Cholangitis-Ursodeoxycholic Acid Study Group. Ursodiol for primary sclerosing cholangitis
-
Lindor KD, Mayo Primary Sclerosing Cholangitis-Ursodeoxycholic Acid Study Group. Ursodiol for primary sclerosing cholangitis. N Engl J Med 1997;336:691-5.
-
(1997)
N Engl J Med
, vol.336
, pp. 691-695
-
-
Lindor, K.D.1
-
14
-
-
6844240876
-
Use of aspirin and other nonsteroidal anti-inflammatory drugs and risk of esophageal and gastric cancer
-
Farrow DC, Vaughan TL, Hansten PD, et al. Use of aspirin and other nonsteroidal anti-inflammatory drugs and risk of esophageal and gastric cancer. Cancer Epidemiol Biomarkers Prev 1998;7:97-102.
-
(1998)
Cancer Epidemiol Biomarkers Prev
, vol.7
, pp. 97-102
-
-
Farrow, D.C.1
Vaughan, T.L.2
Hansten, P.D.3
-
15
-
-
0036204834
-
Chemoprevention of esophageal adenocarcinoma by COX-2 inhibitors in an animal model of Barrett's esophagus
-
see comment
-
Buttar NS, Wang KK, Leontovich O, et al. Chemoprevention of esophageal adenocarcinoma by COX-2 inhibitors in an animal model of Barrett's esophagus [see comment]. Gastroenterology 2002;122: 1101-12.
-
(2002)
Gastroenterology
, vol.122
, pp. 1101-1112
-
-
Buttar, N.S.1
Wang, K.K.2
Leontovich, O.3
-
16
-
-
14944368720
-
COX-2 inhibitors-lessons in drug safety
-
Psaty BM, Furberg CD. COX-2 inhibitors-lessons in drug safety. N Engl J Med 2005;352:1133-5.
-
(2005)
N Engl J Med
, vol.352
, pp. 1133-1135
-
-
Psaty, B.M.1
Furberg, C.D.2
-
17
-
-
58349118248
-
Unlike esophageal squamous cells, Barrett's epithelial cells resist apoptosis by activating the nuclear factor-κB pathway
-
Hormi-Carver K, Zhang X, Zhang HY, et al. Unlike esophageal squamous cells, Barrett's epithelial cells resist apoptosis by activating the nuclear factor-κB pathway. Cancer Res 2009;69:672-7.
-
(2009)
Cancer Res
, vol.69
, pp. 672-677
-
-
Hormi-Carver, K.1
Zhang, X.2
Zhang, H.Y.3
-
18
-
-
42349109605
-
Bile acid exposure up-regulates tuberous sclerosis complex 1/mammalian target of rapamycin pathway in Barrett's-associated esophageal adenocarcinoma
-
Yen CJ, Izzo JG, Lee DF, et al. Bile acid exposure up-regulates tuberous sclerosis complex 1/mammalian target of rapamycin pathway in Barrett's-associated esophageal adenocarcinoma. Cancer Res 2008;68:2632-40.
-
(2008)
Cancer Res
, vol.68
, pp. 2632-2640
-
-
Yen, C.J.1
Izzo, J.G.2
Lee, D.F.3
-
19
-
-
0037139613
-
The effect of selective cyclooxygenase-2 inhibition in Barrett's esophagus epithelium: An in vitro study
-
Buttar NS, Wang KK, Anderson MA, et al. The effect of selective cyclooxygenase-2 inhibition in Barrett's esophagus epithelium: an in vitro study. J Natl Cancer Inst 2002;94:422-9.
-
(2002)
J Natl Cancer Inst
, vol.94
, pp. 422-429
-
-
Buttar, N.S.1
Wang, K.K.2
Anderson, M.A.3
-
20
-
-
0037138743
-
Nonsteroidal anti-inflammatory drugs as anticancer agents: Mechanistic, pharmacologic, and clinical issues
-
Thun MJ, Henley SJ, Patrono C. Nonsteroidal anti-inflammatory drugs as anticancer agents: mechanistic, pharmacologic, and clinical issues. J Natl Cancer Inst 2002;94:252-66.
-
(2002)
J Natl Cancer Inst
, vol.94
, pp. 252-266
-
-
Thun, M.J.1
Henley, S.J.2
Patrono, C.3
-
22
-
-
0026665209
-
Ursodeoxycholic acid therapy in cystic fibrosis-associated liver disease: A dose-response study
-
Colombo C, Crosignani A, Assaisso M, et al. Ursodeoxycholic acid therapy in cystic fibrosis-associated liver disease: a dose-response study. Hepatology 1992;16:924-30.
-
(1992)
Hepatology
, vol.16
, pp. 924-930
-
-
Colombo, C.1
Crosignani, A.2
Assaisso, M.3
-
23
-
-
0032965548
-
Toxic bile acids in gastro-oesophageal reflux disease: Influence of gastric acidity
-
Nehra D, Howell P, Williams CP, Pye JK, Beynon J. Toxic bile acids in gastro-oesophageal reflux disease: influence of gastric acidity. Gut 1999;44:598-602. (Pubitemid 29195903)
-
(1999)
Gut
, vol.44
, Issue.5
, pp. 598-602
-
-
Nehra, D.1
Howell, P.2
Williams, C.P.3
Pye, J.K.4
Beynon, J.5
-
24
-
-
0034954161
-
A conserved α-helical motif mediates the interaction of Sp1-like transcriptional repressors with the corepressor mSin3A
-
Zhang JS, Moncrieffe MC, Kaczynski J, Ellenrieder V, Prendergast FG, Urrutia R. A conserved α-helical motif mediates the interaction of Sp1-like transcriptional repressors with the corepressor mSin3A. Mol Cell Biol 2001;21:5041-9.
-
(2001)
Mol Cell Biol
, vol.21
, pp. 5041-5049
-
-
Zhang, J.S.1
Moncrieffe, M.C.2
Kaczynski, J.3
Ellenrieder, V.4
Prendergast, F.G.5
Urrutia, R.6
-
25
-
-
0141625268
-
An mSin3A interaction domain links the transcriptional activity of KLF11 with its role in growth regulation
-
Fernandez-Zapico ME, Mladek A, Ellenrieder V, Folch-Puy E, Miller L, Urrutia R. An mSin3A interaction domain links the transcriptional activity of KLF11 with its role in growth regulation. EMBO J 2003;22: 4748-58.
-
(2003)
EMBO J
, vol.22
, pp. 4748-4758
-
-
Fernandez-Zapico, M.E.1
Mladek, A.2
Ellenrieder, V.3
Folch-Puy, E.4
Miller, L.5
Urrutia, R.6
-
26
-
-
33847710203
-
p38-mediated inactivation of cyclin D1/cyclin-dependent kinase 4 stimulates nucleolar translocation of RelA and apoptosis in colorectal cancer cells
-
Thoms HC, Dunlop MG, Stark LA. p38-mediated inactivation of cyclin D1/cyclin-dependent kinase 4 stimulates nucleolar translocation of RelA and apoptosis in colorectal cancer cells. Cancer Res 2007;67: 1660-9.
-
(2007)
Cancer Res
, vol.67
, pp. 1660-1669
-
-
Thoms, H.C.1
Dunlop, M.G.2
Stark, L.A.3
-
27
-
-
0036917814
-
Ursodeoxycholic acid and F(6)- D(3) inhibit aberrant crypt proliferation in the rat azoxymethane model of colon cancer: Roles of cyclin D1 and E-cadherin
-
Wali RK, Khare S, Tretiakova M, et al. Ursodeoxycholic acid and F(6)- D(3) inhibit aberrant crypt proliferation in the rat azoxymethane model of colon cancer: roles of cyclin D1 and E-cadherin. Cancer Epidemiol Biomarkers Prev 2002;11:1653-62.
-
(2002)
Cancer Epidemiol Biomarkers Prev
, vol.11
, pp. 1653-1662
-
-
Wali, R.K.1
Khare, S.2
Tretiakova, M.3
-
28
-
-
0035848867
-
Cell cycle. Checking two steps
-
Kastan MB. Cell cycle. Checking two steps. Nature 2001;410:766-7.
-
(2001)
Nature
, vol.410
, pp. 766-767
-
-
Kastan, M.B.1
-
29
-
-
58149506283
-
GLI1 is regulated through Smoothened-independent mechanisms in neoplastic pancreatic ducts and mediates PDAC cell survival and transformation
-
Nolan-Stevaux O, Lau J, Truitt ML, et al. GLI1 is regulated through Smoothened-independent mechanisms in neoplastic pancreatic ducts and mediates PDAC cell survival and transformation. Genes Dev 2009;23:24-36.
-
(2009)
Genes Dev
, vol.23
, pp. 24-36
-
-
Nolan-Stevaux, O.1
Lau, J.2
Truitt, M.L.3
-
30
-
-
68149124175
-
Blockade of hedgehog signaling pathway as a therapeutic strategy for pancreatic cancer
-
Xu FG, Ma QY, Wang Z. Blockade of hedgehog signaling pathway as a therapeutic strategy for pancreatic cancer. Cancer Lett 2009;283: 119-24.
-
(2009)
Cancer Lett
, vol.283
, pp. 119-124
-
-
Xu, F.G.1
Ma, Q.Y.2
Wang, Z.3
-
31
-
-
0030628655
-
Colorectal cancer and nonsteroidal antiinflammatory drugs
-
Smalley WE, DuBois RN. Colorectal cancer and nonsteroidal antiinflammatory drugs. Adv Pharmacol 1997;39:1-20.
-
(1997)
Adv Pharmacol
, vol.39
, pp. 1-20
-
-
Smalley, W.E.1
DuBois, R.N.2
-
32
-
-
10644268444
-
Review article: Barrett's oesophagus and associated adenocarcinoma-a UK perspective
-
Fitzgerald RC. Review article: Barrett's oesophagus and associated adenocarcinoma-a UK perspective. Aliment Pharmacol Ther 2004; 20:45-9.
-
(2004)
Aliment Pharmacol Ther
, vol.20
, pp. 45-49
-
-
Fitzgerald, R.C.1
-
33
-
-
33644837942
-
Non-steroidal anti-inflammatory drugs for cancer prevention: Promise, perils and pharmacogenetics
-
DOI 10.1038/nrc1801, PII N1801
-
Ulrich CM, Bigler J, Potter JD. Non-steroidal anti-inflammatory drugs for cancer prevention: promise, perils and pharmacogenetics. Nat Rev Cancer 2006;6:130-40. (Pubitemid 43361545)
-
(2006)
Nature Reviews Cancer
, vol.6
, Issue.2
, pp. 130-140
-
-
Ulrich, C.M.1
Bigler, J.2
Potter, J.D.3
-
34
-
-
9144236811
-
Nonsteroidal anti-inflammatory drug use associated with reduced incidence of adenocarcinomas of the esophagus and gastric cardia that overexpress cyclin D1: A population-based study
-
Gammon MD, Terry MB, Arber N, et al. Nonsteroidal anti-inflammatory drug use associated with reduced incidence of adenocarcinomas of the esophagus and gastric cardia that overexpress cyclin D1: a population-based study. Cancer Epidemiol Biomarkers Prev 2004;13:34-9.
-
(2004)
Cancer Epidemiol Biomarkers Prev
, vol.13
, pp. 34-39
-
-
Gammon, M.D.1
Terry, M.B.2
Arber, N.3
-
35
-
-
0034650771
-
Chemoprevention of colon cancer by specific cyclooxygenase-2 inhibitor, celecoxib, administered during different stages of carcinogenesis
-
Reddy BS, Hirose Y, Lubet R, et al. Chemoprevention of colon cancer by specific cyclooxygenase-2 inhibitor, celecoxib, administered during different stages of carcinogenesis. Cancer Res 2000;60: 293-7.
-
(2000)
Cancer Res
, vol.60
, pp. 293-297
-
-
Reddy, B.S.1
Hirose, Y.2
Lubet, R.3
-
36
-
-
61349140122
-
Combination chemoprevention for colon cancer targeting polyamine synthesis and inflammation
-
Gerner EW, Meyskens FL, Jr. Combination chemoprevention for colon cancer targeting polyamine synthesis and inflammation. Clin Cancer Res 2009;15:758-61.
-
(2009)
Clin Cancer Res
, vol.15
, pp. 758-761
-
-
Gerner, E.W.1
Meyskens Jr., F.L.2
-
37
-
-
0019127924
-
Combination chemoprevention of cancer
-
Sporn MB. Combination chemoprevention of cancer. Nature 1980; 287:107-8.
-
(1980)
Nature
, vol.287
, pp. 107-108
-
-
Sporn, M.B.1
-
38
-
-
0345646455
-
Cellular kinetics in Barrett's epithelium carcinogenic sequence: Roles of apoptosis, bcl-2 protein, and cellular proliferation
-
Lauwers GY, Kandemir O, Kubilis PS, Scott GV. Cellular kinetics in Barrett's epithelium carcinogenic sequence: roles of apoptosis, bcl-2 protein, and cellular proliferation. Mod Pathol 1997;10:1201-8. (Pubitemid 28049720)
-
(1998)
Modern Pathology
, vol.10
, Issue.12
, pp. 1201-1208
-
-
Lauwers, G.Y.1
Kandemir, O.2
Kubilis, P.S.3
Scott, G.V.4
-
39
-
-
0035890616
-
p16(INK4a) lesions are common, early abnormalities that undergo clonal expansion in Barrett's metaplastic epithelium
-
Wong DJ, Paulson TG, Prevo LJ, et al. p16(INK4a) lesions are common, early abnormalities that undergo clonal expansion in Barrett's metaplastic epithelium. Cancer Res 2001;61:8284-9.
-
(2001)
Cancer Res
, vol.61
, pp. 8284-8289
-
-
Wong, D.J.1
Paulson, T.G.2
Prevo, L.J.3
-
40
-
-
0035211027
-
Duodenal reflux induces cyclooxygenase-2 in the esophageal mucosa of rats: Evidence for involvement of bile acids
-
Zhang F, Altorki NK, Wu YC, Soslow RA, Subbaramaiah K, Dannenberg AJ. Duodenal reflux induces cyclooxygenase-2 in the esophageal mucosa of rats: evidence for involvement of bile acids. Gastroenterology 2001;121:1391-9.
-
(2001)
Gastroenterology
, vol.121
, pp. 1391-1399
-
-
Zhang, F.1
Altorki, N.K.2
Wu, Y.C.3
Soslow, R.A.4
Subbaramaiah, K.5
Dannenberg, A.J.6
-
41
-
-
1642633053
-
Bmi1 is essential for cerebellar development and is overexpressed in human medulloblastomas
-
Leung C, Lingbeek M, Shakhova O, et al. Bmi1 is essential for cerebellar development and is overexpressed in human medulloblastomas. Nature 2004;428:337-41.
-
(2004)
Nature
, vol.428
, pp. 337-341
-
-
Leung, C.1
Lingbeek, M.2
Shakhova, O.3
-
42
-
-
0032808138
-
Gli proteins encode context-dependent positive and negative functions implications for development and disease
-
Ruiz i Altaba A. Gli proteins encode context-dependent positive and negative functions implications for development and disease. Development 1999;126:3205-16.
-
(1999)
Development
, vol.126
, pp. 3205-3216
-
-
Ruiz I Altaba, A.1
-
43
-
-
0142227025
-
Developmental biology informs cancer: The emerging role of the hedgehog signaling pathway in upper gastrointestinal cancers
-
DOI 10.1016/S1535-6108(03)00246-0
-
Xie K, Abbruzzese JL. Developmental biology informs cancer: the emerging role of the hedgehog signaling pathway in upper gastrointestinal cancers. Cancer Cell 2003;4:245-7. (Pubitemid 37329787)
-
(2003)
Cancer Cell
, vol.4
, Issue.4
, pp. 245-247
-
-
Xie, K.1
Abbruzzese, J.L.2
-
44
-
-
2942533929
-
Hedgehog signalling in colorectal tumour cells: Induction of apoptosis with cyclopamine treatment
-
Qualtrough D, Buda A, Gaffield W, Williams AC, Paraskeva C. Hedgehog signalling in colorectal tumour cells: induction of apoptosis with cyclopamine treatment. Int J Cancer 2004;110:831-7.
-
(2004)
Int J Cancer
, vol.110
, pp. 831-837
-
-
Qualtrough, D.1
Buda, A.2
Gaffield, W.3
Williams, A.C.4
Paraskeva, C.5
-
45
-
-
72749094687
-
Hedgehog pathway activation and epithelial-to-mesenchymal transitions during myofibroblastic transformation of rat hepatic cells in culture and cirrhosis
-
Choi SS, Omenetti A, Witek RP, et al. Hedgehog pathway activation and epithelial-to-mesenchymal transitions during myofibroblastic transformation of rat hepatic cells in culture and cirrhosis. Am J Physiol 2009;297:1093-106.
-
(2009)
Am J Physiol
, vol.297
, pp. 1093-1106
-
-
Choi, S.S.1
Omenetti, A.2
Witek, R.P.3
-
46
-
-
0033590144
-
Gli genes in development and cancer
-
Matise MP, Joyner AL. Gli genes in development and cancer. Oncogene 1999;18:7852-9.
-
(1999)
Oncogene
, vol.18
, pp. 7852-7859
-
-
Matise, M.P.1
Joyner, A.L.2
-
47
-
-
6044243650
-
Hedgehog signalling in prostate regeneration, neoplasia and metastasis
-
Karhadkar SS, Bova GS, Abdallah N, et al. Hedgehog signalling in prostate regeneration, neoplasia and metastasis. Nature 2004;431: 707-12.
-
(2004)
Nature
, vol.431
, pp. 707-712
-
-
Karhadkar, S.S.1
Bova, G.S.2
Abdallah, N.3
-
48
-
-
4344586961
-
Hedgehog signaling pathway is a new therapeutic target for patients with breast cancer
-
DOI 10.1158/0008-5472.CAN-04-0416
-
Kubo M, Nakamura M, Tasaki A, et al. Hedgehog signaling pathway is a new therapeutic target for patients with breast cancer. Cancer Res 2004;64:6071-4. (Pubitemid 39129406)
-
(2004)
Cancer Research
, vol.64
, Issue.17
, pp. 6071-6074
-
-
Kubo, M.1
Nakamura, M.2
Tasaki, A.3
Yamanaka, N.4
Nakashima, H.5
Nomura, M.6
Kuroki, S.7
Katano, M.8
-
49
-
-
0242268525
-
Widespread requirement for Hedgehog ligand stimulation in growth of digestive tract tumours
-
Berman DM, Karhadkar SS, Maitra A, et al. Widespread requirement for Hedgehog ligand stimulation in growth of digestive tract tumours. Nature 2003;425:846-51.
-
(2003)
Nature
, vol.425
, pp. 846-851
-
-
Berman, D.M.1
Karhadkar, S.S.2
Maitra, A.3
|